Ting Sun

Ting Sun


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2023 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
TSTing Sun
Ting Sun
BLBin Liu
Bin Liu
YLYanyan Li
Yanyan Li
JWJie Wu
Jie Wu
YCYufei Cao
Yufei Cao
WYWei Yang
Wei Yang
Background: Chimeric antigen receptor (CAR)-T immunotherapy fails to treat solid tumors due in part to immunosuppressive microenvironment. Excess lactate produced by tumor glycolysis increases CAR-T immunosuppression. The mechanism of lactate inducing the formation of immunosuppressive microenvironment remains to be further explored. Methods: Immunocyte subpopulations and molecular characteristics were analyzed in the orthotopic xenografts of nude mice using flow cytometry assay and immunohistochemical staining after oxamate, a lactate dehydrogenase A (LDHA) inhibitor, and control T or CAR-T cells injection alone or in combination. RT-qPCR, western blot, flow cytometry, immunofluorescence, luciferase reporter assay, chromatin immunoprecipitation and ELISA were performed to measure the effect of lactate on the regulation of CD39, CD73 and CCR8 in cultured glioma stem cells, CD4 + T cells or macrophages. Results: Oxamate promoted immune activation of tumor-infiltrating CAR-T cells through altering the phenotypes of immune molecules and increasing regulatory T (Treg) cells infiltration in a glioblastoma mouse model. Lactate accumulation within cells upregulated CD39, CD73 and CCR8 expressions in both lactate-treated cells and glioma stem cells-co-cultured CD4 + T cells and macrophages, and intracellular lactate directly elevated the activities of these gene promotors through histone H3K18 lactylation. Conclusions: Utilizing lactate generation inhibitor not only reprogramed glucose metabolism of cancer stem cells, but also alleviated immunosuppression of tumor microenvironment and reduced tumor-infiltrating CAR-Treg cells, which may be a potential strategy to enhance CAR-T function in glioblastoma therapy.

7 October 2019 in Oncogene
Verified
Journal Article
Closed access
PDF file
WYWei Yang
Wei Yang
YLYanyan Li
Yanyan Li
RGRuoling Gao
Ruoling Gao
ZXZenghe Xiu
Zenghe Xiu
TSTing Sun
Ting Sun

1 February 2018 in Cancer Letters
Verified
Journal Article
Closed access
WYWei Yang
Wei Yang
YLYingying Liu
Yingying Liu
RGRuoling Gao
Ruoling Gao
HYHongquan Yu
Hongquan Yu
TSTing Sun
Ting Sun

6 May 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
WYWei Yang
Wei Yang
HYHongquan Yu
Hongquan Yu
YSYueming Shen
Yueming Shen
YLYingying Liu
Yingying Liu
ZYZhanshan Yang
Zhanshan Yang
TSTing Sun
Ting Sun
MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/-catenin pathway MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway

5 March 2020 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
TSTing Sun
Ting Sun
WYWei Yang
Wei Yang
STSneh Toprani
Sneh Toprani
WGWei Guo
Wei Guo
LHLile He
Lile He
XWXinhui Wang
Xinhui Wang
Background: The current successful clinical use of agents promoting robust anti-tumor immunity in cancer patients warrants noting that radiation therapy (RT) induces immunogenic cell death (ICD) of tumor cells, which can generate anti-tumor immune responses. However, breast cancer stem cells (BCSCs) are resistant to RT and RT alone usually failed to mount an anti-tumor immune response. Methods: High aldehyde dehydrogenase activity (ALDH)bright and CD44+/CD24−/ESA+ cancer cells, previously shown to have BCSC properties, were isolated from human MDA-MB-231 and UACC-812 breast cancer cell lines by flow cytometer. Flow sorted BCSCs and non-BCSCs were further tested for their characteristic of stemness by mammosphere formation assay. Induction of ICD in BCSCs vs. non-BCSCs in response to different in vitro treatments was determined by assessing cell apoptosis and a panel of damage-associated molecular pattern molecules (DAMPs) by flow and enzyme-linked immunosorbent assay (ELISA). Results: We found that ionizing radiation (IR) triggered a lower level of ICD in BCSCs than non-BCSCs. We then investigated the ability of disulfiram/cooper (DSF/Cu) which is known to preferentially induce cancer stem cells (CSCs) apoptosis to enhance IR-induced ICD of BCSCs. The results indicate that DSF/Cu induced a similar extent of IDC in both BCSCs and non-BCSCs and rendered IR-resistant BCSCs as sensitive as non-BCSCs to IR-induced ICD. IR and DSF/Cu induced ICD of BCSCs could be partly reversed by pre-treatment of BCSCs with a reactive oxygen species (ROS) scavenger and XBP1s inhibitors. Conclusion: DSF/Cu rendered IR-resistant BCSCs as sensitive as non-BCSCs to IR-induced ICD. Our data demonstrate the potential of IR and DSF/Cu to induce ICD in BCSCs and non-BCSCs leading to robust immune responses against not only differentiated/differentiating breast cancer cells but also BCSCs, the root cause of cancer formation, progression and metastasis. Graphical

1 September 2017 in Experimental Cell Research
Verified
Journal Article
Closed access
YSYueming Shen
Yueming Shen
YLYingying Liu
Yingying Liu
TSTing Sun
Ting Sun
WYWei Yang
Wei Yang